The Indian life sciences consulting market in 2026 is showcasing a noteworthy shift from cost-centric outsourcing to high-value innovation. This growth trajectory can be attributed to AI integration, regulatory shifts, and the proliferation of Global Capability Centers (GCCs). Leveraging advanced technologies for drug discovery, digital clinical trials, and early-phase studies have been steadily driving the market’s growth bandwagon.

Today, If we speak of the country’s expansion of GCCs, India is solidifying its role as a premier hub for Life Sciences GCCs,...  >>More